Literature DB >> 8391891

Detection of bovine leukemia virus proviral DNA in individual cells.

M L Mirsky1, Y Da, H A Lewin.   

Abstract

We have developed a method of analyzing individual cells to detect proviral DNA of the bovine leukemia virus (BLV) using flow cytometry and PCR. Individual cells of the BL3* cell line, which contain multiple integrated copies of the BLV provirus, and the uninfected cell line BL3(0), were sorted into wells of a 96-well plate. Following cell lysis, portions of the BLV envelope (ENV) and cellular prolactin (PRL) genes were amplified simultaneously using PCR. Viral and cellular products of first-round PCR were amplified separately in a second round of PCR using "heminested" primers. Separation of the PCR products by polyacrylamide gel electrophoresis yielded distinct fragments of the predicted sizes. The operational sensitivity of this method for the detection of virus was > 90% when testing single infected cells. In addition, we were able to reliably amplify DNA from a single BL3* cell among as many as 10(5) BL3(0) cells and established that the sensitivity for detecting a single infected cell among 20, 100, or 1000 uninfected cells was at least 90%. Estimates of low percentages of infected cells were obtained by applying probability theory to results of experiments conducted on wells containing more than one cell. Using these methods, B lymphocytes obtained from the peripheral blood of BLV-infected cattle were tested for proviral DNA. BLV ENV was identified in 76.9 +/- 4.9% of single B cells tested from a seropositive animal with persistent lymphocytosis (PL), but in only 0.033 +/- 0.009% of B cells from another seropositive cow without PL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391891     DOI: 10.1101/gr.2.4.333

Source DB:  PubMed          Journal:  PCR Methods Appl        ISSN: 1054-9803


  8 in total

1.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.

Authors:  O Orlik; G A Splitter
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Detection by PCR of Neospora caninum in fetal tissues from spontaneous bovine abortions.

Authors:  T V Baszler; L J Gay; M T Long; B A Mathison
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis.

Authors:  F Dequiedt; E Hanon; P Kerkhofs; P P Pastoret; D Portetelle; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.

Authors:  G H Cantor; T F McElwain; T A Birkebak; G H Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

Review 7.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 8.  Applications of DNA amplification techniques in veterinary diagnostics.

Authors:  M Pfeffer; M Wiedmann; C A Batt
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.